1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Summary in patients with CIN
Patient No. Age (yr)/Sex Pre-SCr Post-SCr Pre-eGFR HTN DM CAD Diuretic Prolonged CSR Read. Contrast Volume (mL) Contrast Ratio 1 65/M 1.32 2.12 43.2 + – + – + – 200 0.78 2 75/M 0.69 0.88 84.3 + – – – + – 190 0.45 3 74/M 0.82 1.06 70.1 – + – – – + 175 0.45 4 76/M 1.25 1.79 43.9 + – – – – – 190 0.72 5 84/M 1.24 1.65 43.0 + – – – – – 90 0.46 6 73/M 0.92 1.33 62.0 + – – – + – 100 0.38 7 79/M 0.72 0.91 79.3 + – + – + – 95 0.21